Skip to main content
Aptamer Sciences Inc logo

Aptamer Sciences Inc — Investor Relations & Filings

Ticker · 291650 ISIN · KR7291650000 KO Manufacturing
Open in API
Filings indexed 230 across all filing types
Latest filing 2024-11-29 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 291650

About Aptamer Sciences Inc

https://aptsci.com/en/

Aptamer Sciences Inc. is a clinical-stage biopharmaceutical company specializing in aptamer technology. The company has established a proprietary, integrated platform for the discovery and development of aptamer-based therapeutics and diagnostics. Its primary focus is on oncology, utilizing its Aptamer-Drug Conjugate (ApDC™) platform to create targeted cancer treatments. The lead candidate, AST-201, is an ApDC targeting the GPC3 protein, which is highly expressed in solid tumors such as liver cancer. The company is advancing AST-201 through clinical trials to evaluate its safety and efficacy. The development pipeline also includes other innovative platforms like Aptamer Radioligand Conjugates (ApRC) and Aptamer Immune Stimulator Conjugates (ApIS), aimed at addressing unmet medical needs in hemato-oncology and other areas. Aptamer Sciences leverages its technology to develop novel therapies with the potential for high specificity and efficacy.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) from Aptamer Science, specifically detailing a 'Capital Increase Decision' (유상증자결정). It is a regulatory filing that provides specific details on the issuance of new shares, pricing, and subscription methods. Since it involves a change in capital structure through a rights offering, it falls under the 'Share Issue/Capital Change' category.
2024-11-29 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the issuance price (발행조건확정) for a capital increase (유상증자). This is a formal regulatory filing required for public offerings of securities. While it relates to capital, it is a comprehensive regulatory document rather than a simple announcement, and it fits the definition of a regulatory filing for securities issuance.
2024-11-29 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 1% confidence The document is a 'Correction Report' (정정신고) for an 'Investment Prospectus' (투자설명서) filed by Aptamer Science. It details specific amendments made to the original prospectus, including updated financial figures (issue price determination) and disclosures related to the company's Q3 report. Since this is a formal regulatory filing amending a prospectus for a capital raise (securities offering), it falls under the category of Regulatory Filings (RNS) as it is a specific type of mandatory disclosure document that does not fit into the other specialized categories like 10-K or ER.
2024-11-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders (directors/major shareholders) to disclose changes in their shareholdings or related securities. This corresponds to the 'Director's Dealing' category, which covers insider trades and ownership changes.
2024-11-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a specific individual (Ryu Sung-ho, CTO) in Aptamer Science. This is a standard regulatory filing in South Korea for insider trading/shareholding changes, which corresponds to the 'Director's Dealing' category.
2024-11-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by major shareholders and special related parties, including acquisition and disposal methods. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-11-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.